Intersect ENT, Inc. et al. vs. New Amsterdam, LLC
Explore the PTAB proceeding IPR2024-00713 filed by Intersect ENT, Inc. et al. on 2024-03-25. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
IPR2024-00713
Filing Date
2024-03-25
Accorded Filing Date
2024-03-25
Institution Decision Date
—
Last Modified Date
2024-06-27
Proceeding Type
IPR
Termination Date
2024-06-21
Trial Status
Terminated-Settled
Parties & Counsel
Petitioner
Intersect ENT, Inc. et al.
Represented By
Wittenzellner, Johnet alPatent Owner / Respondent
New Amsterdam, LLC
Represented By
Fuller, Michaelet alTribunal & Venue
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 1600 - Biotechnology & Organic Chemistry
Patent Information
Respondent Application Number
10200355
Respondent Patent Number
6916483
External Links
Respondent Inventor
James Ralph et al
Respondent Tech Center
TC 1600 - Biotechnology & Organic Chemistry
Address and Attorney/Agent Information
Power of Attorney & Correspondence
Firm
/ Entity Name
Norris McLaughlin, P.A.
Customer
Number
23526
Address
7 Times Square, 21st Floor, New York, NY, 10036-6524, UNITED STATES
Attorney / Agent Information
| Reg # | Name | Phone |
|---|---|---|
| 32431 | Andrew Parfomak | 212-808-0700 |
| 33141 | Kurt Briscoe | 212-808-0700 |
| 33531 | Bruce Londa | 212-808-0700 |
| 48641 | Brian Anscomb | 312-218-8212 |
| 56750 | David Siegel | 212-557-7200 |
| 59139 | Joseph Farco | 212-415-7967 |
Proceeding Documents
31
12
Notice: refund approved NOTICE
2024-06-27
FILING PARTY: BOARD
11
Refund Request OTHER
2024-06-24
FILING PARTY: PETITIONER
10
DECISION Settlement Prior to Institution of Trial 37 C.F.R. § 42.74 TERMINATE
2024-06-21
FILING PARTY: BOARD
9
Corrected Request to Treat as Confidential OTHER
2024-06-17
FILING PARTY: PETITIONER
8
Corrected Joint Motion to Terminate MOTION
2024-06-17
FILING PARTY: PETITIONER